Trethera News

Gloved hand of a scientist in a lab writing on a digital stilus with a digital pen.Blue DNA illustrationPhoto of a series of test tubes.Scientific microscope with visual representation of DNA helix

FDA Provides Trethera Clearance to Initiate TRE-515 Clinical Trial in Healthy Volunteers to Study Food Effect and Biomarkers

July 30, 2025

The FDA has cleared Trethera's TRE‑515 clinical trial in healthy volunteers to study food effects and key biomarkers like deoxycytidine (dC), supporting precision dosing and enriched biomarker datasets.

Read More

FDA Grants Fast Track Designation for TRE-515 in Combination with Radiation Therapy for the Treatment of Metastatic Castration Resistant Prostate Cancer

July 9, 2025

The FDA granted Fast Track designation to TRE‑515 in combination with precision-guided radiation therapy for metastatic castration-resistant prostate cancer (mCRPC), supporting accelerated development in one of the most aggressive forms of prostate cancer.

Read More

Trethera Secures New License, Strengthening TRE-515 Intellectual Property Portfolio and Extending Market Exclusivity to 2045

June 3, 2025

Trethera entered an exclusive worldwide license with UCLA, strengthening TRE‑515’s intellectual property estate—which now includes new therapeutic uses—and securing U.S. and global market exclusivity through at least February 2045.

Read More

Globally Recognized Expert in Rare Autoimmune Neurologic Diseases, Dr. Benjamin Greenberg, Joins Trethera Scientific Advisory Board

May 21, 2025

Trethera has appointed Dr. Benjamin Greenberg, a leading expert in rare autoimmune neurologic disorders, to its Scientific Advisory Board to support TRE‑515’s development in demyelinating diseases like ADEM and optic neuritis.

Read More

Trethera To Participate in Panel Discussion and Research Poster Competition At Los Angeles Bioscience Ecosystem Summit 2025

April 22, 2025

Trethera will appear on a CEO panel and deliver a poster presentation on TRE‑515 at the 2025 Los Angeles Bioscience Ecosystem Summit, highlighting work on autoimmune disease models and fostering industry collaboration.

Read More